Rapid incorporation of ?-3 fatty acids into colonic tissue after oral supplementation in patients with colorectal cancer: a randomized, placebo-controlled intervention trial
Rapid incorporation of ?-3 fatty acids into colonic tissue after oral supplementation in patients with colorectal cancer: a randomized, placebo-controlled intervention trial
Background: The purpose of the study was to examine whether a preoperative supplement with ?-3 fatty acids (FAs) leads to their incorporation into colonic tissue in patients scheduled for colorectal cancer surgery. This would be of interest because ?-3 FAs have potential beneficial (local) immunological effects that might benefit these patients.
Methods: In a randomized, double-blind, prospective, placebo-controlled, single-center intervention trial, patients referred for elective colorectal cancer surgery received either an ?-3 FA–enriched oral nutrition supplement (ONS) (200 mL twice daily) providing 2.0 g of eicosapentaenoic acid (EPA) and 1.0 g of docosahexaenoic acid (DHA) per day or a standard ONS for 7 days before surgery. Tissue samples from healthy colonic tissue (mucosa and muscular layer) were obtained during surgery, and tissue fatty acid composition was analyzed by gas chromatography.
Results: EPA was significantly higher in colonic mucosa (P = .001) and in the colonic muscular layer (P = .004) in the ?-3 FA group compared with controls. Patients in the ?-3 FA group also tended to have higher docosapentaenoic acid and DHA levels in colonic tissue.
Conclusions: EPA is incorporated rapidly into colonic mucosa and colonic muscular layer in patients given 3 g of ?-3 FA daily for 7 days before surgery for colorectal cancer. This may lead to potential beneficially effects on (local) immune function, which might benefit these patients.
abdominal surgery, arachidonic acid, colon, fish oil, immunomodulation, ?-3 fatty acids
617-624
Sorensen, L.S.
19ec5f08-4030-481a-9720-b463b492c739
Rasmussen, H.H.
ce22c561-0d29-469e-86d4-0b5997eae4d6
Aardestrup, I.V.
b52fd9b7-07a7-4e38-bea2-f1d5793634b3
Thorlacius-Ussing, O.
01324bcb-7710-4b1d-bdd6-11691df706ba
Lindorff-Larsen, K.
5d244713-731d-4bd7-8860-5006a71d5464
Schmidt, E.B.
4874f79f-b771-46da-917a-8d8a8c912176
Calder, P.C.
1797e54f-378e-4dcb-80a4-3e30018f07a6
July 2014
Sorensen, L.S.
19ec5f08-4030-481a-9720-b463b492c739
Rasmussen, H.H.
ce22c561-0d29-469e-86d4-0b5997eae4d6
Aardestrup, I.V.
b52fd9b7-07a7-4e38-bea2-f1d5793634b3
Thorlacius-Ussing, O.
01324bcb-7710-4b1d-bdd6-11691df706ba
Lindorff-Larsen, K.
5d244713-731d-4bd7-8860-5006a71d5464
Schmidt, E.B.
4874f79f-b771-46da-917a-8d8a8c912176
Calder, P.C.
1797e54f-378e-4dcb-80a4-3e30018f07a6
Sorensen, L.S., Rasmussen, H.H., Aardestrup, I.V., Thorlacius-Ussing, O., Lindorff-Larsen, K., Schmidt, E.B. and Calder, P.C.
(2014)
Rapid incorporation of ?-3 fatty acids into colonic tissue after oral supplementation in patients with colorectal cancer: a randomized, placebo-controlled intervention trial.
Journal of Parenteral and Enteral Nutrition, 38 (5), .
(doi:10.1177/0148607113491782).
(PMID:23788002)
Abstract
Background: The purpose of the study was to examine whether a preoperative supplement with ?-3 fatty acids (FAs) leads to their incorporation into colonic tissue in patients scheduled for colorectal cancer surgery. This would be of interest because ?-3 FAs have potential beneficial (local) immunological effects that might benefit these patients.
Methods: In a randomized, double-blind, prospective, placebo-controlled, single-center intervention trial, patients referred for elective colorectal cancer surgery received either an ?-3 FA–enriched oral nutrition supplement (ONS) (200 mL twice daily) providing 2.0 g of eicosapentaenoic acid (EPA) and 1.0 g of docosahexaenoic acid (DHA) per day or a standard ONS for 7 days before surgery. Tissue samples from healthy colonic tissue (mucosa and muscular layer) were obtained during surgery, and tissue fatty acid composition was analyzed by gas chromatography.
Results: EPA was significantly higher in colonic mucosa (P = .001) and in the colonic muscular layer (P = .004) in the ?-3 FA group compared with controls. Patients in the ?-3 FA group also tended to have higher docosapentaenoic acid and DHA levels in colonic tissue.
Conclusions: EPA is incorporated rapidly into colonic mucosa and colonic muscular layer in patients given 3 g of ?-3 FA daily for 7 days before surgery for colorectal cancer. This may lead to potential beneficially effects on (local) immune function, which might benefit these patients.
This record has no associated files available for download.
More information
e-pub ahead of print date: 20 June 2013
Published date: July 2014
Keywords:
abdominal surgery, arachidonic acid, colon, fish oil, immunomodulation, ?-3 fatty acids
Organisations:
Human Development & Health
Identifiers
Local EPrints ID: 366394
URI: http://eprints.soton.ac.uk/id/eprint/366394
ISSN: 0148-6071
PURE UUID: e5706701-e6c7-4b0f-b633-2b7d40492df5
Catalogue record
Date deposited: 27 Jun 2014 14:28
Last modified: 15 Mar 2024 02:50
Export record
Altmetrics
Contributors
Author:
L.S. Sorensen
Author:
H.H. Rasmussen
Author:
I.V. Aardestrup
Author:
O. Thorlacius-Ussing
Author:
K. Lindorff-Larsen
Author:
E.B. Schmidt
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics